Remicade 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FBGMY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,669
Award facts
- Contract value 100% obligated
- $13,669.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,669.41 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vehicle designated SPE2DX and running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as a primary supplier for military and veteran healthcare systems through this comprehensive global pharmaceutical support contract. Remicade is a biologic immunosuppressant medication used primarily for treating inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis. The IDC vehicle enables flexible procurement of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide, with DLA Troop Support currently planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FBGMY?
SPE2DB25FBGMY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FBGMY worth?
The government has obligated $13,669 on SPE2DB25FBGMY.
Is contract SPE2DB25FBGMY an order under another contract?
Yes. SPE2DB25FBGMY is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBGMY competed?
The extent of competition for SPE2DB25FBGMY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award